CrossRef Forward Linking Search Results

This Article:

David Michelson, Douglas Faries, Joachim Wernicke, Douglas Kelsey, Katherine Kendrick, F. Randy Sallee, Thomas Spencer, and the Atomoxetine ADHD Study Group
Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response Study
Pediatrics 2001 108: e83

has been cited by the following articles in journals that are participating in CrossRef's forward linking service:

A randomised controlled trial into the effects of food on ADHD
Lidy M.J. Pelsser, Klaas Frankena, Jan Toorman, Huub F.J. Savelkoul, Rob Rodrigues Pereira, and Jan K. Buitelaar
European Child & Adolescent Psychiatry (2008)
Link to Article
Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder
Fariba Arabgol, Leily Panaghi, and Paria Hebrani
European Child & Adolescent Psychiatry (2008)
Link to Article
Biodistribution and radiation dosimetry of the norepinephrine transporter radioligand (S,S)-[18F]FMeNER-D2: a human whole-body PET study
Akihiro Takano, Christer Halldin, Andrea Varrone, Per Karlsson, Nils Sjöholm, James B. Stubbs, Magnus Schou, Anu J. Airaksinen, Johannes Tauscher, and Balázs Gulyás
European Journal of Nuclear Medicine and Molecular Imaging (2008) 35: 630
Link to Article
An Open-Label Trial of Reboxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
Mehdi Tehrani-Doost, Shirin Moallemi, and Zahra Shahrivar
Journal of Child and Adolescent Psychopharmacology (2008) 18: 179
Link to Article
Psychopharmacological and Other Treatments in Preschool Children with Attention-Deficit/Hyperactivity Disorder: Current Evidence and Practice
Jaswinder K. Ghuman, L. Eugene Arnold, and Bruno J. Anthony
Journal of Child and Adolescent Psychopharmacology (2008) 18: 413
Link to Article
Switching from Neurostimulant Therapy to Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder
Suyash Prasad and Chris Steer
Pediatric Drugs (2008) 10: 39
Link to Article
A Modeled Economic Evaluation Comparing Atomoxetine with Stimulant Therapy in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder in the United Kingdom
Suzi Cottrell, Dominic Tilden, Paul Robinson, Jay Bae, Jorge Arellano, Eric Edgell, Mike Aristides, and Kristina S. Boye
Value in Health (2008) 11: 376
Link to Article
‘I Bambini e le Droghe’: The Right to Ritalin vs the Right to Childhood in Italy
Giovanni Frazzetto, Sinéad Keenan, and Ilina Singh
BioSocieties (2007) 2
Link to Article
Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents
Mark L Wolraich, Laura McGuinn, and Melissa Doffing
Drug Safety (2007) 30: 17
Link to Article
Drug and non-drug treatments of children with ADHD and tic disorders
Yann Poncin, Denis G. Sukhodolsky, Joseph McGuire, and Lawrence Scahill
European Child & Adolescent Psychiatry (2007) 16: 78
Link to Article
Emerging drugs for attention-deficit/hyperactivity disorder
Richard H Weisler
Expert Opinion on Emerging Drugs (2007) 12: 423
Link to Article
Review of long-acting stimulants in the treatment of attention deficit hyperactivity disorder
Richard H Weisler
Expert Opinion on Pharmacotherapy (2007) 8: 745
Link to Article
Quetiapine Addition in Methylphenidate Treatment-Resistant Adolescents with Comorbid ADHD, Conduct/Oppositional-Defiant Disorder, and Aggression: A Prospective, Open-Label Study
William G. Kronenberger, Ann L. Giauque, Deborah E. Lafata, Bradley N. Bohnstedt, Laura E. Maxey, and David W. Dunn
Journal of Child and Adolescent Psychopharmacology (2007) 17: 334
Link to Article
Efficacy and Safety of Atomoxetine in Adolescents with Attention-Deficit/Hyperactivity Disorder and Major Depression
Mark E. Bangs, Graham J. Emslie, Thomas J. Spencer, Janet L. Ramsey, Christopher Carlson, Eric J. Bartky, Joan Busner, David A. Duesenberg, Paras Harshawat, and Stuart L. Kaplan
Journal of Child and Adolescent Psychopharmacology (2007) 17: 407
Link to Article
Open-Label Amantadine in Children with Attention-Deficit/Hyperactivity Disorder
Renato Donfrancesco, Dario Calderoni, and Benedetto Vitiello
Journal of Child and Adolescent Psychopharmacology (2007) 17: 657
Link to Article
Effects of Atomoxetine on Growth in Children with Attention-Deficit/Hyperactivity Disorder Following up to Five Years of Treatment
Thomas J. Spencer, Christopher J. Kratochvil, R. Bart Sangal, Keith E. Saylor, Charles E. Bailey, David W. Dunn, Daniel A. Geller, Charles D. Casat, Robert S. Lipetz, and Rakesh Jain
Journal of Child and Adolescent Psychopharmacology (2007) 17: 689
Link to Article
Effectiveness of Atomoxetine and Quality of Life in Children with Attention-Deficit/Hyperactivity Disorder as Perceived by Patients, Parents, and Physicians in an Open-Label Study
Peter M. Wehmeier, Ralf W. Dittmann, Alexander Schacht, Anette Minarzyk, Martin Lehmann, Kathrin Sevecke, and Gerd Lehmkuhl
Journal of Child and Adolescent Psychopharmacology (2007) 17: 813
Link to Article
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
&NA;
Journal of the American Academy of Child & Adolescent Psychiatry (2007) 46: 894
Link to Article
Atomoxetine Treatment for Pediatric Patients With Attention-Deficit/Hyperactivity Disorder With Comorbid Anxiety Disorder
DANIEL GELLER, CRAIG DONNELLY, FRANK LOPEZ, RICHARD RUBIN, JEFFREY NEWCORN, VIRGINIA SUTTON, ROSALIE BAKKEN, MARTIN PACZKOWSKI, DOUGLAS KELSEY, and CALVIN SUMNER
Journal of the American Academy of Child & Adolescent Psychiatry (2007) 46: 1119
Link to Article
The Neuropsychology of Amphetamine and Opiate Dependence: Implications for Treatment
Karen D Ersche and Barbara J Sahakian
Neuropsychology Review (2007) 17: 317
Link to Article
Pharmacologic Treatment of Attention-Deficit/Hyperactivity Disorder: Efficacy, Safety and Mechanisms of Action
Steven R. Pliszka
Neuropsychology Review (2007) 17: 61
Link to Article
Testing Computational Models of Dopamine and Noradrenaline Dysfunction in Attention Deficit/Hyperactivity Disorder
Michael J Frank, Amy Santamaria, Randall C O'Reilly, and Erik Willcutt
Neuropsychopharmacology (2007) 32: 1583
Link to Article
Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents—meta-analysis and meta-regression analysis
Jackie Y. W. Cheng, Ronald Y. L. Chen, John S. N. Ko, and Emil M. L. Ng
Psychopharmacology (2007) 194: 197
Link to Article
Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data
Joseph Biederman, Thomas J. Spencer, Jeffrey H. Newcorn, Haitao Gao, Denái R. Milton, Peter D. Feldman, and Michael M. Witte
Psychopharmacology (2007) 190: 31
Link to Article
Possible association of the alpha-2A adrenergic receptor gene (ADRA2A) with symptoms of attention-deficit/hyperactivity disorder
Bing Wang, Yufeng Wang, Rulun Zhou, Jun Li, Qiujin Qian, Li Yang, Lili Guan, and Stephen V. Faraone
American Journal of Medical Genetics Part B Neuropsychiatric Genetics (2006) 141b: 130
Link to Article
Agreement between parent and child report of quality of life in children with attention-deficit/hyperactivity disorder
A. F. Klassen, A. Miller, and S. Fine
Child Care Health and Development (2006) 32: 397
Link to Article
Treatment of attention deficits in neurological disorders
Elizabeth Coulthard, Victoria Singh-Curry, and Masud Husain
Current Opinion in Neurology (2006) 19: 613???618
Link to Article
Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder
Philip Hazell, Shuyu Zhang, Tomasz Wolańczyk, Joanne Barton, Mats Johnson, Alessandro Zuddas, Marina Danckaerts, Andrula Ladikos, David Benn, and Roni Yoran-Hegesh
European Child & Adolescent Psychiatry (2006) 15: 105
Link to Article
A comparison of North American versus non-North American ADHD study populations
Jan K. Buitelaar, Joanne Barton, Marina Danckaerts, Edgar Friedrichs, Christopher Gillberg, Philip L. Hazell, Hans Hellemans, Mats Johnson, Luuk J. Kalverdijk, and Gabriele Masi
European Child & Adolescent Psychiatry (2006) 15: 177
Link to Article
Treatment of ADHD with French maritime pine bark extract, Pycnogenol®
Jana Trebatická, Soňa Kopasová, Zuzana Hradečná, Kamil Činovský, Igor Škodáček, Ján Šuba, Jana Muchová, Ingrid Žitňanová, Iweta Waczulíková, and Peter Rohdewald
European Child & Adolescent Psychiatry (2006) 15: 329
Link to Article
Study design, baseline patient characteristics and intervention in a cross-cultural framework: results from the ADORE study
Ulrich Preuss, Stephen J. Ralston**, Gisli Baldursson, Bruno Falissard, Maria J. Lorenzo, Rob Rodrigues Pereira, Laurens Vlasveld, and David Coghill
European Child & Adolescent Psychiatry (2006) 15: i4
Link to Article
Cross-cultural reliability and validity of ADHD assessed by the ADHD Rating Scale in a pan-European study
Manfred Döpfner, Hans-Christoph Steinhausen, David Coghill, Søren Dalsgaard, Lynne Poole, Stephen J. Ralston**, and Aribert Rothenberger
European Child & Adolescent Psychiatry (2006) 15: i46
Link to Article
Discriminative-Stimulus, Self-Reported, Performance, and Cardiovascular Effects of Atomoxetine in Methylphenidate-Trained Humans.
Joshua A. Lile, William W. Stoops, Todd M. Durell, Paul E. A. Glaser, and Craig R. Rush
Experimental and Clinical Psychopharmacology (2006) 14: 136
Link to Article
Impact of atomoxetine on health-related quality of life and functional status in patients with ADHD
Louis S Matza, Maria N Stoeckl, Jodi M Shorr, and Joseph A Johnston
Expert Review of Pharmacoeconomics & Outcomes Research (2006) 6: 379
Link to Article
Psychopharmacology Notes. Nonstimulant Medications for the Treatment of ADHD
Adrienne Rains and Lawrence Scahill
Journal of Child and Adolescent Psychiatric Nursing (2006) 19: 44
Link to Article
Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms in Children with Pervasive Developmental Disorders: APilot Study
Pieter W. Troost, Mark-Peter Steenhuis, Hanneke G. Tuynman-Qua, Luuk J. Kalverdijk, Jan K. Buitelaar, Ruud B. Minderaa, and Pieter J. Hoekstra
Journal of Child and Adolescent Psychopharmacology (2006) 16: 611
Link to Article
Open-Label Atomoxetine for Attention-Deficit/ Hyperactivity Disorder Symptoms Associated with High-Functioning Pervasive Developmental Disorders
David J. Posey, Ryan E. Wiegand, Jennifer Wilkerson, Melissa Maynard, Kimberly A. Stigler, and Christopher J. McDougle
Journal of Child and Adolescent Psychopharmacology (2006) 16: 599
Link to Article
Placebo-Controlled Study of the Effects of Atomoxetine on Bladder Control in Children With Nocturnal Enuresis
Calvin R. Sumner, Kory J. Schuh, Virginia K. Sutton, Robert Lipetz, and Douglas K. Kelsey
Journal of Child and Adolescent Psychopharmacology (2006) 16: 699
Link to Article
Atomoxetine Treatment in Children and Adolescents with Attention-Deficit Hyperactivity Disorder: What Are the Long-Term Health-Related Quality-of-Life Outcomes?
Amy R. Perwien, Christopher J. Kratochvil, Douglas E. Faries, Brigette S. Vaughan, Thomas Spencer, and Ronald T. Brown
Journal of Child and Adolescent Psychopharmacology (2006) 16: 713
Link to Article
Decreased Use of Clonidine Following Treatment With Atomoxetine in Children With ADHD
Joseph A. Johnston, Wenyu Ye, David L. Van Brunt, Gerhardt Pohl, and Calvin R. Sumner
Journal of Clinical Psychopharmacology (2006) 26: 389
Link to Article
ADHD
FRANK A. L??PEZ
Journal of Developmental & Behavioral Pediatrics (2006) 27: 410
Link to Article
The Texas Children's Medication Algorithm Project
STEVEN R. PLISZKA, M. LYNN CRISMON, CARROLL W. HUGHES, C. KEITH CORNERS, GRAHAM J. EMSLIE, PETER S. JENSEN, JAMES T. McCRACKEN, JAMES M. SWANSON, and MOLLY LOPEZ
Journal of the American Academy of Child & Adolescent Psychiatry (2006) 45: 642
Link to Article
Effects of Long-Term Atomoxetine Treatment for Young Children With Attention-Deficit/Hyperactivity Disorder
CHRISTOPHER J. KRATOCHVIL, TIMOTHY E. WILENS, LAURENCE L. GREENHILL, HAITAO GAO, KURT D. BAKER, PETER D. FELDMAN, and DOUGLAS L. GELOWITZ
Journal of the American Academy of Child & Adolescent Psychiatry (2006) 45: 919
Link to Article
Atomoxetine for Hyperactivity in Autism Spectrum Disorders
L. EUGENE ARNOLD, MICHAEL G. AMAN, AMELIA M. COOK, ANDREA N. WITWER, KRISTY L. HALL, SUSAN THOMPSON, and YASER RAMADAN
Journal of the American Academy of Child & Adolescent Psychiatry (2006) 45: 1196
Link to Article
Atomoxetine: a novel treatment for child and adult ADHD
Marcialee Ledbetter
Neuropsychiatric Disease and Treatment (2006) 2: 455
Link to Article
Comparison of the Inhibitory and Excitatory Effects of ADHD Medications Methylphenidate and Atomoxetine on Motor Cortex
Donald L Gilbert, Keith R Ridel, Floyd R Sallee, Jie Zhang, Tara D Lipps, and Eric M Wassermann
Neuropsychopharmacology (2006) 31: 442
Link to Article
Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2
Nicholas Seneca, Balázs Gulyás, Andrea Varrone, Magnus Schou, Anu Airaksinen, Johannes Tauscher, Francois Vandenhende, William Kielbasa, Lars Farde, and Robert B. Innis
Psychopharmacology (2006) 188: 119
Link to Article
Atomoxetine in the treatment of children, adolescents and adults with attention deficit hyperactivity disorder
Atilla Turgay
Therapy (2006) 3: 19
Link to Article
Atomoxetine in the treatment of children, adolescents and adults with attention deficit hyperactivity disorder
Atilla Turgay
Therapy (2006) 3: 19
Link to Article
Clinical Pharmacokinetics of Atomoxetine
John-Michael Sauer, Barbara J Ring, and Jennifer W Witcher
Clinical Pharmacokinetics (2005) 44: 571
Link to Article
Detecting Treatment Emergent Adverse Events in Clinical Trials
Joachim F Wernicke, Douglas Faries, Den??i Milton, and Karen Weyrauch
Drug Safety (2005) 28: 1057
Link to Article
The scientific foundation for understanding attention-deficit/hyperactivity disorder as a valid psychiatric disorder
Stephen V. Faraone
European Child & Adolescent Psychiatry (2005) 14: 1
Link to Article
The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder
Sunke Himpel, Tobias Banaschewski, Cord-Alexander Heise, and Aribert Rothenberger
Expert Opinion on Drug Safety (2005) 4: 311
Link to Article
Do adrenergically active drugs have a role in the first-line treatment of attention-deficit/hyperactivity disorder?
Philip Hazell
Expert Opinion on Pharmacotherapy (2005) 6: 1989
Link to Article
Safety, efficacy and extended duration of action of mixed amphetamine salts extended-release capsules for the treatment of ADHD
Richard H Weisler
Expert Opinion on Pharmacotherapy (2005) 6: 1003
Link to Article
Quality of life of children with attention deficit hyperactivity disorder
Anne F Klassen
Expert Review of Pharmacoeconomics & Outcomes Research (2005) 5: 95
Link to Article
ADHD rating scale IV: psychometric properties from a multinational study as clinician-administered instrument
S. Zhang, D.E. Faries, M. Vowles, and D. Michelson
International Journal of Methods in Psychiatric Research (2005) 14: 186
Link to Article
Atomoxetine Treatment in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder
Jeffrey H Newcorn, Thomas J Spencer, Joseph Biederman, Den??i R Milton, and David Michelson
Journal of the American Academy of Child & Adolescent Psychiatry (2005) 44: 240
Link to Article
A Randomized, Placebo-Controlled Study of Once-Daily Atomoxetine in the School Setting in Children With ADHD
Margaret Weiss, Rosemary Tannock, Christopher Kratochvil, David Dunn, Jesus Velez-Borras, Christine Thomason, Roy Tamura, Douglas Kelsey, Linda Stevens, and Albert J Allen
Journal of the American Academy of Child & Adolescent Psychiatry (2005) 44: 647
Link to Article
The Answerable Question and a Hierarchy of Evidence
John Hamilton
Journal of the American Academy of Child & Adolescent Psychiatry (2005) 44: 596
Link to Article
Atomoxetine Alone or Combined With Fluoxetine for Treating ADHD With Comorbid Depressive or Anxiety Symptoms
Christopher J Kratochvil, Jeffrey H Newcorn, L Eugene Arnold, David Duesenberg, Graham J Emslie, Humberto Quintana, Elias H Sarkis, Karen Dineen Wagner, Haitao Gao, and David Michelson
Journal of the American Academy of Child & Adolescent Psychiatry (2005) 44: 915
Link to Article
Parent-Proxy EQ-5D Ratings of Children with Attention-Deficit Hyperactivity Disorder in the US and the UK
Louis S Matza, Kristina Secnik, Sally Mannix, and F Randy Sallee
PharmacoEconomics (2005) 23: 777
Link to Article
Psychometric validation of the child health questionnaire (CHQ) in a sample of children and adolescents with attention-deficit/hyperactivity disorder
Anne M. Rentz, Louis S. Matza, Kristina Secnik, Andrine Swensen, and Dennis A. Revicki
Quality of Life Research (2005) 14: 719
Link to Article
Recent Advances in Pharmacotherapies for the Externalizing Disorders
Ronald T. Brown
School Psychology Quarterly (2005) 20: 118
Link to Article
Review of new compounds available in Australia for the treatment of attention-deficit hyperactivity disorder
Philip Hazell
Australasian Psychiatry (2004) 12: 369
Link to Article
Atomoxetine in Children and Adolescents with ADHD
Abel Ickowicz
Child and Adolescent Psychopharmacology News (2004) 9: 7
Link to Article
Atomoxetine
Tim Yates
Child and Adolescent Psychopharmacology News (2004) 9: 1
Link to Article
New Formulations of Stimulants for Attention-Deficit Hyperactivity Disorder
Daniel F Connor and Ronald J Steingard
CNS Drugs (2004) 18: 1011
Link to Article
???Pay attention??? to stimulants in attention-deficit hyperactivity disorder when other psychiatric disorders exist
&NA;
Drugs & Therapy Perspectives (2004) 20: 12
Link to Article
Atomoxetine in the treatment of attention deficit hyperactivity disorder
Christopher J Kratochvil, Brigette S Vaughan, Joan M Daughton, Michelle L Mayfield-Jorgensen, and William J Burke
Expert Review of Neurotherapeutics (2004) 4: 601
Link to Article
Aggression and disruptive behavior disorders in children and adolescents
Atilla Turgay
Expert Review of Neurotherapeutics (2004) 4: 623
Link to Article
Changes in Symptoms and Adverse Events After Discontinuation of Atomoxetine in Children and Adults With Attention Deficit/Hyperactivity Disorder
Joachim F. Wernicke, Lenard Adler, Thomas Spencer, Scott A. West, Albert J. Allen, John Heiligenstein, Den??i Milton, Dustin Ruff, W. Jeffrey Brown, and Douglas Kelsey
Journal of Clinical Psychopharmacology (2004) 24: 30
Link to Article
Effects of Once-Daily Osmotic-Release Methylphenidate on Blood Pressure and Heart Rate in Children with Attention-Deficit/Hyperactivity Disorder
Timothy E. Wilens, Joseph Biederman, and Marc Lerner
Journal of Clinical Psychopharmacology (2004) 24: 36
Link to Article
Improvement in Health-Related Quality of Life in Children with ADHD
AMY R. PERWIEN, DOUGLAS E. FARIES, CHRISTOPHER J. KRATOCHVIL, CALVIN R. SUMNER, DOUGLAS K. KELSEY, and ALBERT J. ALLEN
Journal of Developmental & Behavioral Pediatrics (2004) 25: 264
Link to Article
The Link Between Health-Related Quality of Life and Clinical Symptoms Among Children with Attention-Deficit Hyperactivity Disorder
LOUIS S. MATZA, ANNE M. RENTZ, KRISTINA SECNIK, ANDRINE R. SWENSEN, DENNIS A. REVICKI, DAVID MICHELSON, THOMAS SPENCER, JEFFREY H. NEWCORN, and CHRISTOPHER J. KRATOCHVIL
Journal of Developmental & Behavioral Pediatrics (2004) 25: 166
Link to Article
Adolescents with Attention-Deficit/Hyperactivity Disorder: An Overview of Empirically Based Treatments
RUSSELL A. BARKLEY
Journal of Psychiatric Practice (2004) 10: 39
Link to Article
Association of Norepinephrine Transporter Gene With Methylphenidate Response
LI YANG, YU-FENG WANG, JUN LI, and STEPHEN V FARAONE
Journal of the American Academy of Child & Adolescent Psychiatry (2004) 43: 1154
Link to Article
Relapse Prevention in Pediatric Patients With ADHD Treated With Atomoxetine: A Randomized, Double-Blind, Placebo-Controlled Study
DAVID MICHELSON, JAN K BUITELAAR, MARINA DANCKAERTS, CHRISTOPHER GILLBERG, THOMAS J SPENCER, ALESSANDRO ZUDDAS, DOUGLAS E FARIES, SHUYU ZHANG, and JOSEPH BIEDERMAN
Journal of the American Academy of Child & Adolescent Psychiatry (2004) 43: 896
Link to Article
Evaluation of the Reinforcing Effects of Monoamine Reuptake Inhibitors Under a Concurrent Schedule of Food and I.V. Drug Delivery in Rhesus Monkeys
Maciej Gasior, Jack Bergman, Mary Jeanne Kallman, and Carol A Paronis
Neuropsychopharmacology (2004)
Link to Article
Therapeutic Monitoring of Antidepressants in the Era of Pharmacogenetics Studies
C. B. Eap, E. Jaquenoud Sirot, and P. Baumann
Therapeutic Drug Monitoring (2004) 26: 152
Link to Article
Assessment of Health-Related Quality of Life in Children: A Review of Conceptual, Methodological, and Regulatory Issues
Louis S. Matza, Andrine R. Swensen, Emuella M. Flood, Kristina Secnik, and Nancy Kline Leidy
Value in Health (2004) 7: 79
Link to Article

Katie Daley
Current Opinion in Pediatrics (2003) 15: 216
Link to Article
Cardiovascular Effects of Atomoxetine in Children, Adolescents, and Adults
Joachim F Wernicke, Douglas Faries, Donald Girod, Jeffrey W Brown, Haitao Gao, Douglas Kelsey, Humberto Quintana, Robert Lipetz, David Michelson, and John Heiligenstein
Drug Safety (2003) 26: 729
Link to Article
New approaches to developing antidepressants by enhancing monoaminergic neurotransmission
Frank P Bymaster, Robert K McNamara, and Pierre V Tran
Expert Opinion on Investigational Drugs (2003) 12: 531
Link to Article
Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder
Christopher J Kratochvil, Brigette S Vaughan, Martin J Harrington, and William J Burke
Expert Opinion on Pharmacotherapy (2003) 4: 1165
Link to Article
Bupropion for attentiondeficit hyperactivity and comorbid disorders
W Burleson Daviss, Raymond J Pan, and James M Perel
Expert Review of Neurotherapeutics (2003) 3: 9
Link to Article
Costs associated with attention deficit hyperactivity disorder: overview and future projections
James P Guevara and David S Mandell
Expert Review of Pharmacoeconomics & Outcomes Research (2003) 3: 201
Link to Article
Methodological Issues and Controversies in Clinical Trials with Child and Adolescent Patients with Bipolar Disorder: Report of a Consensus Conference
Gabrielle A. Carlson, Peter S. Jensen, Robert L. Findling, Roger E. Meyer, Joseph Calabrese, Melissa P. DelBello, Graham Emslie, Laurie Flynn, Frederick Goodwin, and Martha Hellander
Journal of Child and Adolescent Psychopharmacology (2003) 13: 13
Link to Article
Ten-Year Review of Rating Scales. V: Scales Assessing Attention-Deficit/Hyperactivity Disorder
BRENT R. COLLETT, JENEVA L. OHAN, and KATHLEEN M. MYERS
Journal of the American Academy of Child & Adolescent Psychiatry (2003) 42: 1015
Link to Article
Review of Safety Assessment Methods Used in Pediatric Psychopharmacology
LAURENCE L. GREENHILL, BENEDETTO VITIELLO, MARK A. RIDDLE, PRUDENCE FISHER, ERIN SHOCKEY, JOHN S. MARCH, JEROME LEVINE, JANE FRIED, HOWARD ABIKOFF, and JULIE M. ZITO
Journal of the American Academy of Child & Adolescent Psychiatry (2003) 42: 627
Link to Article
ATOMOXETINE AND PREGNANCY
Norman E. Alessi and Scott Spalding
Journal of the American Academy of Child & Adolescent Psychiatry (2003) 42: 883
Link to Article
A review of the biological bases of ADHD: What have we learned from imaging studies?
Sarah Durston
Mental Retardation and Developmental Disabilities Research Reviews (2003) 9: 184
Link to Article
Psychiatric Comorbidities in Children with Attention Deficit Hyperactivity Disorder
Steven R Pliszka
Pediatric Drugs (2003) 5: 741
Link to Article
Atomoxetine: A Selective Norepinephrine Reuptake Inhibitor for the Treatment of Attention-Deficit/Hyperactivity Disorder.
Rafael A. Rivas-Vazquez
Professional Psychology Research and Practice (2003) 34: 666
Link to Article
First New ADHD Treatment in 30 Years
Lynn Wimett and Gary Laustsen
The Nurse Practitioner (2003) 28: 50
Link to Article

Kelly Kirby, Lori Rutman, and Henry Bernstein
Current Opinion in Pediatrics (2002) 14: 236
Link to Article

Dave Coghill
Current Opinion in Psychiatry (2002) 15: 361
Link to Article
New drugs for treatment of attention-deficit/hyperactivity disorder
Bowen Chung, Alejandra R Suzuki, and James J McGough
Expert Opinion on Emerging Drugs (2002) 7: 269
Link to Article
Atomoxetine and Methylphenidate Treatment in Children With ADHD: A Prospective, Randomized, Open-Label Trial
CHRISTOPHER J. KRATOCHVIL, JOHN H. HEILIGENSTEIN, RALF DITTMANN, THOMAS J. SPENCER, JOSEPH BIEDERMAN, JOACHIM WERNICKE, JEFFREY H. NEWCORN, CHARLES CASAT, DEN??I MILTON, and DAVID MICHELSON
Journal of the American Academy of Child & Adolescent Psychiatry (2002) 41: 776
Link to Article